Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
03/2003
03/27/2003WO2002028844A1 Thiazole or oxazole derivatives
03/27/2003US20030060488 Drug comprising combination
03/27/2003US20030060461 Cyclic diamine compound with condensed-ring groups
03/27/2003CA2465978A1 Inhibitors of histone deacetylase
03/27/2003CA2460360A1 Systematical administration of some oxazolidinones, e.g. linezolid, for the treatment for ocular infections
03/27/2003CA2460244A1 Simplified sarcodictyn derivatives as anti-tumor agents
03/27/2003CA2423885A1 Thiazole and oxazole derivatives
03/26/2003EP1295875A1 Heterocyclic compounds
03/26/2003EP1295874A2 Retroviral protease inhibiting compounds
03/26/2003EP1294823A1 Double-spiro organic compounds and electroluminescent devices
03/26/2003EP1294717A2 A thiazine oxazolidinone
03/26/2003EP1294704A1 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
03/26/2003EP1294691A1 Serine protease inhibitors
03/26/2003EP1294362A1 Novel process for preparing crystalline particles
03/26/2003EP1025085B1 Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof
03/26/2003CN1405159A Method for continuously preparing substituted oxazole
03/26/2003CN1405158A Method for preparing substituted oxazole
03/26/2003CN1103775C Vitronectin receptor antagonists, their preparation and use
03/26/2003CN1103590C Use of thiazolidinediones to prevent or delay on set of NIDDM
03/25/2003US6538142 Process for the preparation of metaxalone
03/25/2003US6538140 Complex oxonol infrared radiation sensitive compounds
03/25/2003US6538134 Forming by reacting N-benzylethanolamine with glycoxylic acid in solvent; intermediate in synthesis of substance P receptor antagonists
03/25/2003US6538024 Felbamate derived compounds
03/25/2003US6537986 Oxazolidinone antibacterial agents having a thiocarbonyl funtionality
03/20/2003WO2003022824A1 Oxazolidinone and/or isoxazoline as antibacterial agents
03/20/2003WO2002100845A8 Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/20/2003WO2002067865A3 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
03/20/2003US20030055287 Phthalic acid diamide derivatives, fluorine-containing aniline compounds as starting material, agricultural and horticultural insecticides, and a method for application of the insecticides
03/20/2003US20030055265 Oxazole derivatives
03/20/2003US20030055264 Processes for the preparation of oxo-oxazoline or alloamino acid derivatives
03/20/2003US20030055247 Thiazolyl(pyridyl)ethyne compounds
03/20/2003CA2459766A1 Oxazolidinone and/or isoxazoline as antibacterial agents
03/19/2003EP1292582A1 4-benzyl-2-hydroxy-1,4-oxazin-3-one and polymorphic forms thereof
03/19/2003EP1292581A1 Bicyclic cyclohexylamines and their use as nmda receptor antagonists
03/19/2003EP1292573A2 Substituted thioacetamides
03/19/2003CN1404468A Novel use of phenylheteroalkylamine derivatives
03/19/2003CN1403455A Synthesis of 2-oxazolidone derivate by one still process
03/18/2003US6534201 Organometallic luminescent materials and organic electroluminescent device containing same
03/13/2003WO2003020698A2 Protein tyrosine kinase inhibitors
03/13/2003WO2003020696A1 C2-substituted indane-1-ols and their derivatives, method for their production and their use as medicaments
03/13/2003WO2003020677A2 C2-substituted indane-1-ones and their derivatives, method for their production and their use as medicaments
03/13/2003WO2003020269A1 Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar activators
03/13/2003WO2002078625A3 Therapeutic combinations for cardiovascular and inflammatory indications
03/13/2003WO2002076950A3 Imidiazole derivatives and their use as agonists selective at alpha 2b or 2b/2c adrenergic receptors
03/13/2003WO2002036553A3 Substituted alkanoic acids
03/13/2003US20030050479 Process for the preparation of substituted oxazoles
03/13/2003US20030050478 Converting continuously fed alpha -isocyanoalkyl acid esters derivative in presence of a base into 5-alkoxy-substituted oxazoles and discharging the reaction product continuously from the reactor
03/13/2003US20030050311 A novel phenyl oxazoles, thiazoles, oxazolines, oxadiazoles or benzoxazoles for treating neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, amytrophic lateral sclerosis or cerebral trauma
03/13/2003CA2458527A1 C2-substituted indane-1-ols and their derivatives, method for their production and their use as medicaments
03/12/2003EP1291392A1 Oxonol infrared radiation sensitive compounds
03/12/2003EP1289958A2 BENZOPHENONES AS INHIBITORS OF IL-1$g(b) AND TNF-$g(a)
03/12/2003EP0900198B1 New vitamin d derivatives with carbo- or heterocyclic substituents at c-25, a process for their production, intermediate products and their use for producing medicaments
03/12/2003CN1402716A Substd. oxazoles and thiazoles derivs. as HPPAR alpha activators
03/12/2003CN1402636A Pharmaceutical formulations contg. zolmitriptan
03/12/2003CN1402614A High selective herbicidal phenoxypropionic acid alkoxycarbonyl anilid compounds and method of preparing thereof
03/12/2003CN1401634A 4-guanidinobenzamides antifertility compounds
03/11/2003US6531611 Process for making taxane derivatives
03/11/2003US6531610 Intermediate acylating carbonate
03/11/2003US6531609 Process for the preparation of thiazolidinedione derivatives
03/11/2003US6531604 Useful as medicines having an osteogenesis promoting effect and chondrogensis promoting effect.
03/11/2003US6531470 Oxazolidinone combinatorial libraries, compositions and methods of preparation
03/11/2003US6531424 Complex of a selected transition metal with a monoanionic ligand that has at least three atoms that may coordinate to the transition metal, one of which is an oxygen at and one of which is a nitrogen in an imine radical
03/11/2003US6531241 Anions of equal number to cations to maintain charge neutrality, are disclosed. These spacer groups may be organic or inorganic in origin and may vary in length. The spacer groups may be saturated, containing single bonds, or may have
03/11/2003CA2262837C An asymmetric conjugate addition reaction
03/11/2003CA2146250C Process for preparing taxane derivatives
03/11/2003CA2146155C Process for preparing taxane derivatives
03/06/2003WO2003018762A2 Compositions that bind antiterminator rna and their assays
03/06/2003WO2003018564A1 Vascular wall-selective acat inhibitor
03/06/2003WO2003018553A1 Oral antidiabetic agents
03/06/2003WO2003018535A2 Novel aminobenzoephenones
03/06/2003WO2003018029A1 Anti-bacterial agents based upon oxoanion binding
03/06/2003WO2003018008A1 Apo ai expression accelerating agent
03/06/2003WO2002100844A3 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/06/2003WO2002094770A3 Aminoalcohol derivatives
03/06/2003WO2002085849A3 Process to prepare oxazolidinones
03/06/2003US20030045558 Such as 2-(4-(2-(2-(4-(3,5-dimethyl-isoxazol-4-yl)-phenyl)-5-methyloxazol-4-yl) -ethyoxy)-phenoxy)-2-methylpropionic acid for treatment of diabetes (lowering serum triglycerides)
03/06/2003US20030045545 Immunomodulators, induce cytokine biosynthesis, and antineoplastic agents
03/06/2003US20030044376 Reacting 3,4-dihydroxymethyloxazolidin-2-one with diisocyanate; halogenation
03/06/2003CA2458621A1 Oral antidiabetic agents
03/06/2003CA2458507A1 Compositions that bind antiterminator rna and their assays
03/06/2003CA2455504A1 Anti-bacterial agents based upon oxoanion binding
03/05/2003EP1288206A1 Substituted benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors
03/05/2003EP1287006A1 Antitumoral compounds
03/05/2003EP1286975A1 Biclyclic cyclohexylamines and their use as nmda receptor antagonists
03/05/2003EP1286967A1 Cyclohexane derivatives and their use as therapeutic agents
03/05/2003EP1286673A2 Ligands of integrin receptors
03/05/2003EP1286670A2 Use of therapeutic benzamide derivatives
03/05/2003EP0966447B1 Small molecules useful in the treatment of inflammatory disease
03/05/2003EP0892791B1 N-[[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL]PHENYL]SULFONYLPROPYLAMIDE and its SODIUMSALT AS PRODRUGS OF COX-2 INHIBITORS
03/05/2003EP0627433B1 Process for producing imidazopyridine derivative and intermediate
03/04/2003US6528543 Glucokinase activating for treating type II diabetes; acylurea compound, phenylacetyl-substituted; 1-(2-(3-chloro-phenyl)-3cyclopentyl-propionyl)-3-methyl-urea
03/04/2003US6528534 Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation
03/04/2003US6528528 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
02/2003
02/28/2003WO2002018331A1 Herbicidal benzoyl cyclohexane dione
02/28/2003CA2420917A1 Herbicidally active benzoylcyclohexanediones
02/27/2003WO2003016291A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-RESPONSIVE RECEPTOR δ
02/27/2003WO2003016265A1 Cyclic compound and ppar agonist
02/27/2003WO2002079174A3 Enantioselective synthesis of azetidinone intermediate compounds
02/27/2003WO2002072542A3 Ph-dependent nmda receptor antagonists
02/27/2003US20030040633 Useful for therapy of HIV-related diseases based on its inhibitory action on proteases derived from viruses
1 ... 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 ... 210